CY1111128T1 - Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης - Google Patents

Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης

Info

Publication number
CY1111128T1
CY1111128T1 CY20101100274T CY101100274T CY1111128T1 CY 1111128 T1 CY1111128 T1 CY 1111128T1 CY 20101100274 T CY20101100274 T CY 20101100274T CY 101100274 T CY101100274 T CY 101100274T CY 1111128 T1 CY1111128 T1 CY 1111128T1
Authority
CY
Cyprus
Prior art keywords
steroid
producer
phosphorus
processor
useful
Prior art date
Application number
CY20101100274T
Other languages
English (en)
Inventor
Weiqin Jiang
Zhihua Sui
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1111128T1 publication Critical patent/CY1111128T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Η παρούσα εφεύρεση απευθύνεται σε νέα 17-φωσφορούχα στεροειδή παράγωγα, τις φαρμακευτικές συνθέσεις που τα περιέχουν και στη χρήση τους στην αντιμετώπιση των διαταραχών και των παθήσεων που διαμορφώνονται από μια προγεστερόνη ή γλυκοκορτικοειδή υποδοχέα.
CY20101100274T 2006-02-17 2010-03-22 Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης CY1111128T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77504306P 2006-02-17 2006-02-17
EP07757086A EP1989218B1 (en) 2006-02-17 2007-02-16 17-phosphorous steroid derivatives useful as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
CY1111128T1 true CY1111128T1 (el) 2015-06-11

Family

ID=38330971

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100274T CY1111128T1 (el) 2006-02-17 2010-03-22 Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης

Country Status (15)

Country Link
US (1) US7671045B2 (el)
EP (1) EP1989218B1 (el)
JP (1) JP5230450B2 (el)
CN (1) CN101421290B (el)
AT (1) ATE453660T1 (el)
AU (1) AU2007217095B2 (el)
CA (1) CA2642566C (el)
CY (1) CY1111128T1 (el)
DE (1) DE602007004081D1 (el)
DK (1) DK1989218T3 (el)
ES (1) ES2337521T3 (el)
PL (1) PL1989218T3 (el)
PT (1) PT1989218E (el)
SI (1) SI1989218T1 (el)
WO (1) WO2007098382A2 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0501132A2 (en) * 2005-12-05 2007-06-28 Richter Gedeon Nyrt 17-alpha-cyanomethyl-17betha-hydroxyestra-4,9-diene-3-one of high purity and process for its production
EP1989217B1 (en) * 2006-02-17 2012-06-27 Janssen Pharmaceutica N.V. 11-phosphorous steroid derivatives useful as progesterone receptor modulators
JP5583976B2 (ja) 2007-03-07 2014-09-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的プロゲステロン受容体モジュレーターとしてのステロイド誘導体
CN102617691B (zh) * 2012-01-18 2014-05-14 上海新华联制药有限公司 一种改进的米非司酮中间体制备方法
WO2014060888A1 (en) 2012-10-18 2014-04-24 Lupin Limited Novel process and intermediate for preparation of ulipristal
JP6906525B2 (ja) * 2015-12-23 2021-07-21 オリック ファーマシューティカルズ，インク． グルココルチコイド受容体の阻害剤
WO2017112904A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
JP6995757B2 (ja) 2015-12-23 2022-01-17 オリック ファーマシューティカルズ，インク． グルココルチコイド受容体の阻害剤
PL3523315T3 (pl) 2016-10-07 2021-10-18 Oric Pharmaceuticals, Inc. Inhibitor receptora glukokortykoidowego
CN106810584A (zh) * 2016-12-28 2017-06-09 宁波第二激素厂 烯丙孕素的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
CA2100514C (en) 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
JPH0995496A (ja) * 1995-09-28 1997-04-08 Kaken Pharmaceut Co Ltd ウルソデオキシコール酸誘導体
PT1448592E (pt) * 2001-10-18 2006-07-31 Sterix Ltd Compostos esteroides para inibicao da esteroide sulfatase

Also Published As

Publication number Publication date
SI1989218T1 (sl) 2010-04-30
EP1989218A2 (en) 2008-11-12
JP2009527490A (ja) 2009-07-30
US20070207982A1 (en) 2007-09-06
JP5230450B2 (ja) 2013-07-10
DE602007004081D1 (de) 2010-02-11
CA2642566C (en) 2014-04-15
WO2007098382A3 (en) 2007-11-01
CN101421290B (zh) 2012-09-19
US7671045B2 (en) 2010-03-02
PL1989218T3 (pl) 2010-06-30
DK1989218T3 (da) 2010-04-26
CA2642566A1 (en) 2007-08-30
AU2007217095A1 (en) 2007-08-30
EP1989218B1 (en) 2009-12-30
ATE453660T1 (de) 2010-01-15
AU2007217095B2 (en) 2012-05-03
CN101421290A (zh) 2009-04-29
PT1989218E (pt) 2010-02-01
ES2337521T3 (es) 2010-04-26
WO2007098382A2 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
CY1111128T1 (el) Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
GEP20135793B (en) Heteroaryls amide derivatives and their use as glucokinase activators
CY1113146T1 (el) 11-φωσφο-στεροειδη παραγωγα ως τροποποιητες του υποδοχεα προγεστερονης
MY153057A (en) Tryclic compounds,compositions and methods
WO2008152099A3 (en) Aryl/hetarylamides as modulators of the ep2 receptor
TW200626156A (en) Amido compounds and their use as pharmaceuticals
EA200970835A1 (ru) Индазолы, применяемые для лечения расстройств, опосредуемых эстрогеновым рецептором бета
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
EA200970065A1 (ru) Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
TW200734323A (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
ATE542795T1 (de) Benzylpiperazinderivate als motilin- rezeptorantagonisten
ATE473741T1 (de) Neue imidazolopyrazolderivate als selektive androgen-rezeptor-modulatoren
WO2008109719A3 (en) Steroids derivatives as selective progesterone receptor modulators
EA201290532A1 (ru) Бициклические тиазолы в качестве аллостерических модуляторов рецепторов mglur5
EP1883624A4 (en) D-HOMOANDROSTA-17-YL CARBAMATE DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR LIGANDS
WO2009043577A3 (de) 19-nor-progesterone zur kontrazeption
CY1111110T1 (el) Τετρακυκλικα στεροειδη παραγωγα χρησιμα ως διαμορφωτες υποδοχεα προγεστερονης
CY1113127T1 (el) Οξα στεροειδη παραγωγα ως εκλεκτικοι τροποποιητες υποδοχεων προγεστερονης
UA83142C2 (en) 3-aminocyclopentane carboxyamidine as modulators of chemokine receptors
PT1812417E (pt) Novos derivados de 2h-cromeno como moduladores selectivos do receptor de estrogénio
CY1109795T1 (el) Νεες τρικυκλικες διϋδροπυραζινες ως παραγοντες ανοiγματος του καναλιου καλιου